
Samantha L. Shterengarts
Examiner (ID: 2, Phone: (571)270-5316 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 4131, 1623, 1626 |
| Total Applications | 2313 |
| Issued Applications | 1786 |
| Pending Applications | 96 |
| Abandoned Applications | 469 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14464547
[patent_doc_number] => 20190183913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-20
[patent_title] => Silanol Based Therapeutic Payloads
[patent_app_type] => utility
[patent_app_number] => 16/037447
[patent_app_country] => US
[patent_app_date] => 2018-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16037447
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/037447 | Silanol based therapeutic payloads | Jul 16, 2018 | Issued |
Array
(
[id] => 13533439
[patent_doc_number] => 20180318262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => THIOUREYLENE LIQUID COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/032870
[patent_app_country] => US
[patent_app_date] => 2018-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4508
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16032870
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/032870 | THIOUREYLENE LIQUID COMPOSITIONS | Jul 10, 2018 | Abandoned |
Array
(
[id] => 15828405
[patent_doc_number] => 20200129484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => RAD51 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/623850
[patent_app_country] => US
[patent_app_date] => 2018-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16623850
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/623850 | RAD51 inhibitors | Jul 10, 2018 | Issued |
Array
(
[id] => 14016309
[patent_doc_number] => 20190070148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders
[patent_app_type] => utility
[patent_app_number] => 16/028257
[patent_app_country] => US
[patent_app_date] => 2018-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48975
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16028257
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/028257 | Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders | Jul 4, 2018 | Abandoned |
Array
(
[id] => 16312265
[patent_doc_number] => 20200291003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/629006
[patent_app_country] => US
[patent_app_date] => 2018-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68295
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16629006
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/629006 | Sulfonamide carboxamide compounds | Jul 3, 2018 | Issued |
Array
(
[id] => 15865959
[patent_doc_number] => 20200140383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => 2-(4-CHLOROPHENOXY)-N-((1 -(2-(4-CHLOROPHENOXY)ETHYNAZETIDIN-3-YL)METHYL)ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ATF4 INHIBITORS FOR TREATING CANCER AND OTHER DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/625031
[patent_app_country] => US
[patent_app_date] => 2018-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25840
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625031
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/625031 | 2-(4-CHLOROPHENOXY)-N-((1 -(2-(4-CHLOROPHENOXY)ETHYNAZETIDIN-3-YL)METHYL)ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ATF4 INHIBITORS FOR TREATING CANCER AND OTHER DISEASES | Jul 1, 2018 | Abandoned |
Array
(
[id] => 13837201
[patent_doc_number] => 20190022085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => SUSTAINED-RELEASE BUPRENORPHINE SOLUTIONS
[patent_app_type] => utility
[patent_app_number] => 16/016186
[patent_app_country] => US
[patent_app_date] => 2018-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10119
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16016186
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/016186 | Sustained-release buprenorphine solutions | Jun 21, 2018 | Issued |
Array
(
[id] => 15649413
[patent_doc_number] => 20200087236
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2020-03-19
[patent_title] => COMPOSITIONS OF POLYHYDROXYLATED BENZOPHENONES AND METHODS OF TREATMENT OF NEURODEGENERATIVE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/010030
[patent_app_country] => US
[patent_app_date] => 2018-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11461
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16010030
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/010030 | Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders | Jun 14, 2018 | Issued |
Array
(
[id] => 15649413
[patent_doc_number] => 20200087236
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2020-03-19
[patent_title] => COMPOSITIONS OF POLYHYDROXYLATED BENZOPHENONES AND METHODS OF TREATMENT OF NEURODEGENERATIVE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/010030
[patent_app_country] => US
[patent_app_date] => 2018-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11461
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16010030
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/010030 | Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders | Jun 14, 2018 | Issued |
Array
(
[id] => 15988767
[patent_doc_number] => 20200170254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => OXADIAZOLINE COMPOUND AND FORMULATION FOR CONTROLLING HARMFUL ORGANISMS
[patent_app_type] => utility
[patent_app_number] => 16/613214
[patent_app_country] => US
[patent_app_date] => 2018-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21348
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 332
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16613214
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/613214 | OXADIAZOLINE COMPOUND AND FORMULATION FOR CONTROLLING HARMFUL ORGANISMS | Jun 11, 2018 | Abandoned |
Array
(
[id] => 16703094
[patent_doc_number] => 10953007
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-23
[patent_title] => Compounds useful as modulators of TRPM8
[patent_app_type] => utility
[patent_app_number] => 15/994235
[patent_app_country] => US
[patent_app_date] => 2018-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32562
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15994235
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/994235 | Compounds useful as modulators of TRPM8 | May 30, 2018 | Issued |
Array
(
[id] => 13603859
[patent_doc_number] => 20180353478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => CANNABINOID RECEPTOR ANTAGONISTS/INVERSE AGONISTS USEFUL FOR TREATING METABOLIC DISORDERS, INCLUDING OBESITY AND DIABETES
[patent_app_type] => utility
[patent_app_number] => 15/991705
[patent_app_country] => US
[patent_app_date] => 2018-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10703
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15991705
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/991705 | Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes | May 28, 2018 | Issued |
Array
(
[id] => 17953472
[patent_doc_number] => 11479563
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => Biphenyl compound or salt thereof
[patent_app_type] => utility
[patent_app_number] => 16/616854
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62260
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616854
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616854 | Biphenyl compound or salt thereof | May 24, 2018 | Issued |
Array
(
[id] => 17953472
[patent_doc_number] => 11479563
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => Biphenyl compound or salt thereof
[patent_app_type] => utility
[patent_app_number] => 16/616854
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62260
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616854
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616854 | Biphenyl compound or salt thereof | May 24, 2018 | Issued |
Array
(
[id] => 17953472
[patent_doc_number] => 11479563
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => Biphenyl compound or salt thereof
[patent_app_type] => utility
[patent_app_number] => 16/616854
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62260
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616854
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616854 | Biphenyl compound or salt thereof | May 24, 2018 | Issued |
Array
(
[id] => 17953472
[patent_doc_number] => 11479563
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => Biphenyl compound or salt thereof
[patent_app_type] => utility
[patent_app_number] => 16/616854
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62260
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616854
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616854 | Biphenyl compound or salt thereof | May 24, 2018 | Issued |
Array
(
[id] => 17162911
[patent_doc_number] => 11148998
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-19
[patent_title] => Dimethyl-nonatetraenyl-trimethyl-cyclohexyl compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/987274
[patent_app_country] => US
[patent_app_date] => 2018-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 43
[patent_no_of_words] => 18204
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15987274
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/987274 | Dimethyl-nonatetraenyl-trimethyl-cyclohexyl compounds and uses thereof | May 22, 2018 | Issued |
Array
(
[id] => 13424781
[patent_doc_number] => 20180263933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => METHODS AND COMPOSITIONS FOR INTERFERING WITH EXTRACTION OR CONVERSION OF A DRUG SUSCEPTIBLE TO ABUSE
[patent_app_type] => utility
[patent_app_number] => 15/983597
[patent_app_country] => US
[patent_app_date] => 2018-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13352
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15983597
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/983597 | Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse | May 17, 2018 | Issued |
Array
(
[id] => 16869970
[patent_doc_number] => 20210163437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => DERIVATIVES OF TRICYCLIC SPIROLACTONES AND USES THEREOF IN TREATMENT AND MANAGEMENT OF PAIN
[patent_app_type] => utility
[patent_app_number] => 16/613564
[patent_app_country] => US
[patent_app_date] => 2018-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6871
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16613564
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/613564 | DERIVATIVES OF TRICYCLIC SPIROLACTONES AND USES THEREOF IN TREATMENT AND MANAGEMENT OF PAIN | May 16, 2018 | Abandoned |
Array
(
[id] => 17134756
[patent_doc_number] => 11136302
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Single step process for the synthesis of furan derivatives from carbohydrates
[patent_app_type] => utility
[patent_app_number] => 16/616675
[patent_app_country] => US
[patent_app_date] => 2018-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4194
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616675
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616675 | Single step process for the synthesis of furan derivatives from carbohydrates | May 8, 2018 | Issued |